Ubottomic (Tuberculoid) Leprosy – Complete Medical Guide

Overview

Ubottomic leprosy, more commonly called tuberculoid leprosy, is the mildest form of leprosy (also known as Hansen’s disease). It is characterized by a strong cell‑mediated immune response that limits the spread of Mycobacterium leprae to a few well‑defined skin patches and peripheral nerves.

• Who it affects: Anyone can contract leprosy, but tuberculoid disease is most often seen in individuals with an intact immune system. It is slightly more common in men (≈55 % of cases) and most frequent in people aged 15‑45 years.
• Global prevalence: According to the World Health Organization (WHO), there were 202 000 new leprosy cases worldwide in 2022. Tuberculoid leprosy accounts for roughly 30‑40 % of those cases.
• Geographic distribution: Endemic regions include Brazil, India, Indonesia, Bangladesh, and parts of sub‑Saharan Africa. In the United States, most cases are diagnosed in immigrants or travelers from these areas.

Symptoms

Tuberculoid leprosy produces a limited set of signs because the bacteria are confined to a few areas. The main symptoms include:

Skin lesions

• Hypopigmented or erythematous patches – flat, round or oval, usually 1–5 cm in diameter.
• Loss of sensation – reduced temperature, pain, or touch sensation inside the patch; patients may not notice burns or injuries.
• Well‑defined borders – the edge of the patch is sharp, often with a slightly raised, reddish rim.
• Hair loss (alopecia) within the lesion.
• Dry, smooth skin on the affected area.

Nerve involvement

• Peripheral nerve thickening that can be felt as a rope‑like nodule, most commonly affecting the ulnar, median, common peroneal, or facial nerves.
• Localized numbness or tingling in the hand, foot, or face supplied by the affected nerve.
• Weakness of the muscle group innervated by the involved nerve (e.g., claw‑hand deformity with ulnar nerve disease).

Other possible findings

• Enlarged, painless lymph nodes near the lesion (rare).
• Minimal or absent systemic symptoms such as fever, weight loss, or malaise—these are far more common in the multibacillary forms.

Causes and Risk Factors

Cause

Leprosy is caused by the bacterium Mycobacterium leprae. The organism thrives in cool areas of the body (skin, superficial nerves, nasal mucosa) and spreads primarily via prolonged close contact with an untreated, infectious person.

Risk factors for tuberculoid leprosy

• Living or traveling in endemic regions where the disease is still actively transmitted.
• Close, repeated exposure to untreated leprosy patients, especially household members.
• Genetic susceptibility – certain HLA types (e.g., HLA‑DR2) are linked with a stronger immune response that predisposes to the tuberculoid form.
• Young age (adolescents and young adults) because their immune systems are more likely to mount an effective response.
• Occupational exposure – health workers, teachers, or community volunteers who spend extensive time with patients.

Diagnosis

Diagnosing tuberculoid leprosy requires a combination of clinical assessment, skin testing, and laboratory confirmation.

Clinical evaluation

• Detailed skin and neurological examination focusing on sensation, nerve thickening, and motor function.
• Mapping of lesions and documentation of sensory loss using a monofilament (Semmes‑Weinstein) test.

Laboratory tests

• Skin smear microscopy – Ziehl‑Neelsen stain of slit‑skin smears. In tuberculoid disease, the bacillary index is usually 0 (no organisms seen).
• Skin biopsy – Histopathology reveals well‑formed granulomas with few acid‑fast bacilli (AFB). A positive polymerase chain reaction (PCR) for M. leprae DNA can confirm the diagnosis.
• Serological tests – Lepromin skin test (Moscow or Dharmendra) is typically positive in tuberculoid patients, indicating a strong cell‑mediated response.

Classification

Based on the WHO classification, tuberculoid leprosy falls under the paucibacillary (PB) category** (≤5 skin lesions and/or ≤2 nerve trunks involved). This determines the treatment regimen.